The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Discrete sequential boundaries for clinical trials
Abstract
Pocock (1977), O'Brien & Fleming (1979) and Slud & Wei (1982) have proposed different methods to construct discrete sequential boundaries for clinical trials. These methods require that the total number of decision times be specified in advance. In the present paper, we propose a more flexible way to construct discrete sequential boundaries. The method is based on the choice of a function, α*(t), which characterizes the rate at which the error level α is spent. The boundary at a decision time is determined by α*(t), and by past and current decision times, but does not depend on the future decision times or the total number of decision times.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sequential testing methods, such as Group Sequential Testing (GST) (Jennison and Turnbull, 1999a; Lan and DeMets, 1983; Pocock, 1977; O'Brien and Fleming, 1979) and the Sequential Probability Ratio Test (SPRT) (Wald, 1945c), have long been used to optimize sample size and decision-making in various fields (e.g. clinical trials), by evaluating data at interim points.”
From Stop Guessing When to Stop Testing: Efficient Model Evaluation with Just Enough Data (2026) · cites this paper as Lan and DeMets, 1983
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343787 · Cited by 772
Stochastically curtailed tests in long–term clinical trials
Lan, K. K. G., Simon, R. M., & Halperin, M. (1982) · Sequential Analysis · doi:10.1080/07474948208836014 · Cited by 356
Interim Analyses for Randomized Clinical Trials: The Group Sequential Approach
Pocock, S. (1982) · Biometrics · doi:10.2307/2530298 · Cited by 265
Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic
SLUD, E. V., & Wei, L. (1982) · Journal of the American Statistical Association · doi:10.1080/01621459.1982.10477899 · Cited by 244
Crossing probabilities for a square root boundary by a bessel process
Long, D. M. D. (1981) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928108828182 · Cited by 135
Sequential Testing of the Equality of Two Survival Distributions Using the Modified Savage Statistic
Koziol, J. A., & Petkau, A. J. (1978) · Biometrika · doi:10.1093/biomet/65.3.615 · Cited by 38
A two sample wilcoxon test for progressively censored data
DAVIS, C. E. (1978) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927808827630 · Cited by 23
Rank order tests for grouped data under progressive censoring
Majumdar, H., & Sen, P. K. (1977) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927708827511 · Cited by 9
Cited by
Sorted by citations
Items 801–900 of 1,001
Takii, Y., Mizusawa, J., Kanemitsu, Y., Komori, K., Shiozawa, M., Ohue, M., Ikeda, S., Takiguchi, N., Kobatake, T., Ike, H., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005241 · Cited by 40
Conditional Bias of Point Estimates Following a Group Sequential Test
Fan, X. F., DeMets, D. L., & Lan, K. K. G. (2004) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120037195 · Cited by 40
Self-citationLepage, C., Phelip, J., Cany, L., Faroux, R., Manfrédi, S., Ain, J.-F., Pezet, D., Baconnier, M., Deguiral, P., Terrebone, E., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.03.021 · Cited by 40
Oral cleft prevention program (OCPP)
Wehby, G. L., Goco, N. J., Moretti‐Ferreira, D., Félix, T. M., Richieri‐Costa, A., Padovani, C., de Queirós, F. C., Guimaraes, C. V. N., Pereira, R. M. R., Litavecz, S., et al. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-184 · Cited by 40
Choice of futility boundaries for group sequential designs with two endpoints
Schüler, S., Kieser, M., & Rauch, G. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0387-4 · Cited by 39
Tsai, S., Ding, Y., Shih, M., & Tu, Y. (2020) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13338 · Cited by 40
Group Sequential Designs for Monitoring Survival Probabilities
Lin, D. Y., Shen, L. Z., Ying, Z., & Breslow, N. E. (1996) · Biometrics · doi:10.2307/2533064 · Cited by 40
Statistical interim monitoring of the cardiac arrhythmia suppression trial
Yudi Pawitan, Y., & Hallstrom, A. P. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090915 · Cited by 40
Sequential generalized likelihood ratio tests for vaccine safety evaluation
Shih, M., Lai, T. L., Heyse, J. F., & Chen, J. (2010) · Statistics in Medicine · doi:10.1002/sim.4036 · Cited by 39
Kim, K. B., Legha, S. S., Gonzalez, R. C., Anderson, C. M., Johnson, M. M., Liu, P., Papadopoulos, N. E., Eton, O. E., Plager, C., Buzaid, A. C., et al. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e328314b84a · Cited by 39
Group sequential designs using both type I and type II error probability spending functions
Chang, M. N., Hwang, I. K., & Shin, W. J. (1998) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929808832161 · Cited by 39
McClay, E. F., Bogart, J., Herndon, J. E., Watson, D., Evans, L. S., Seagren, S. L., & Green, M. R. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000139940.52625.d0 · Cited by 39
Two-Stage Adaptive Design for Clinical Trials with Survival Data
Li, G., Shih, W. J., & Wang, Y. (2005) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-200062293 · Cited by 39
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction
Lamas, G. A., Lee, K. L., & Sweeney, M. O. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00963-7 · Cited by 39
Optimal two‐stage designs for clinical trials with binary response
Thall, P. F., Simon, R. M., Ellenberg, S. S., & Shrager, R. I. (1988) · Statistics in Medicine · doi:10.1002/sim.4780070504 · Cited by 39
Texter, M. J., Lees, R. S., Pitt, B., Dinsmore, R. E., & Uprichard, A. C. G. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878518 · Cited by 39
Kuppens, S., & Onghena, P. (2012) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2011.04.002 · Cited by 38
Bayesian randomized clinical trials: From fixed to adaptive design
Yin, G., Lam, C. K., & Shi, H. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.04.010 · Cited by 38
Stopping clinical trials by design
Whitehead, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1553 · Cited by 38
Use of the equivalence approach in reproductive health clinical trials
Piaggio, G. G., & Pinol, A. (2001) · Statistics in Medicine · doi:10.1002/sim.1078 · Cited by 38
Filippatos, G. S., Birnie, D. H., Gold, M. R., Gerritse, B., Hersi, A. S., Jacobs, S., KUSANO, K. F., Leclercq, C., Müllens, W., & Wilkoff, B. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.895 · Cited by 37
The R Package MAMS for Designing Multi-Arm Multi-Stage Clinical Trials
Jaki, T., Pallmann, P., & Magirr, D. (2019) · Journal of Statistical Software · doi:10.18637/jss.v088.i04 · Cited by 37
Sato, Y., Yamada, T., Yoshikawa, T., Machida, R., Mizusawa, J., Katayama, H. G., Tokunaga, M., Boku, N., & Terashima, M. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa113 · Cited by 37
Ziebell, M., Wetterslev, J., Tisell, M., Gluud, C. N., & Juhler, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009706.pub2 · Cited by 36
Group sequential design for comparative diagnostic accuracy studies
Mazumdar, M., & Liu, A. (2003) · Statistics in Medicine · doi:10.1002/sim.1386 · Cited by 37
A General Theory on Stochastic Curtailment for Censored Survival Data
Lin, D. Y., Yao, Q., & Ying, Z. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474145 · Cited by 37
Dose selection in seamless phase II/III clinical trials based on efficacy and safety
Kimani, P., Stallard, N., & Hutton, J. L. (2009) · Statistics in Medicine · doi:10.1002/sim.3522 · Cited by 37
Interim monitoring of clinical trials based on long-term binary endpoints
Marschner, I. C., & Becker, S. L. (2001) · Statistics in Medicine · doi:10.1002/1097-0258(20010130)20:2 · Cited by 36
Hobbs, B. P., Thall, P. F., & Lin, S. H. (2015) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/rssc.12117 · Cited by 36
Visco, A. G., Brubaker, L. T., Richter, H. E., Nygaard, I., Paraiso, M. F. R., Menefee, S. A., Schaffer, J. I., Wei, J. T., Chai, T. C., Janz, N. K., et al. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.019 · Cited by 36
Integrating smoking cessation into mental health care for post-traumatic stress disorder
McFall, M., Saxon, A. J., Thaneemit-Chen, S., Smith, M. W., Joseph, A. M., Carmody, T. P., Beckham, J. C., Malte, C. A., Vertrees, J. E., Boardman, K. D., et al. (2007) · Clinical Trials · doi:10.1177/1740774507076923 · Cited by 36
Idle thoughts of a ‘well‐calibrated’ Bayesian in clinical drug development
Grieve, A. P. (2016) · Pharmaceutical Statistics · doi:10.1002/pst.1736 · Cited by 36
Frank, S. J., Blanchard, P., Lee, J. J., Sturgis, E. M., Kies, M. S., Machtay, M. X., Vikram, B., Garden, A. S., Rosenthal, D. I., Gunn, G. B., et al. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.12.002 · Cited by 36
Acetyl-L-carnitine for patients with hepatic encephalopathy
Martí-Carvajal, A. J., Gluud, C. N., Arévalo-Rodríguez, I., & Martí-Amarista, C. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011451.pub2 · Cited by 36
Bellaver, P., Schaeffer, A. F., Leitão, C. B., Rech, T. H., & Nedel, W. L. (2023) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2023.101202 · Cited by 37
Group Sequential and Adaptive Designs – A Review of Basic Concepts and Points of Discussion
Vandemeulebroecke, M. (2008) · Biometrical Journal · doi:10.1002/bimj.200710436 · Cited by 36
Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints
Kosorok, M. R., Yuan-jun, S., & DeMets, D. L. (2004) · Biometrics · doi:10.1111/j.0006-341x.2004.00146.x · Cited by 36
Self-citationOptimal Timing for Interim Analyses in Clinical Trials
Togo, K., & Iwasaki, M. (2013) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.813522 · Cited by 35
Boese, C. K., Centeno, L., & Walters, R. W. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.00738 · Cited by 35
Schjørring, O. L., Perner, A., Wetterslev, J., Lange, T., Keus, F., Laake, J. H., Okkonen, M., Siegemund, M., Morgan, M., Þormar, K., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13356 · Cited by 35
Friede, T., Stallard, N., & Parsons, N. (2020) · Biometrical Journal · doi:10.1002/bimj.201900020 · Cited by 35
Tanaka, K., Tsutani, Y., Wakabayashi, M., Mizutani, T., Aokage, K., Miyata, Y., Kuroda, H., Saji, H., WATANABE, S.-I. I., & Okada, M. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa092 · Cited by 35
Barthel, F. M. S., Parmar, M., & Royston, P. J. (2009) · Trials · doi:10.1186/1745-6215-10-21 · Cited by 35
Sequential monitoring of clinical trials with correlated responses
Gange, S. J. (1996) · Biometrika · doi:10.1093/biomet/83.1.157 · Cited by 35
Power-enhanced multiple decision functions controlling family-wise error and false discovery rates
Peña, E. A., Habiger, J. D., & Wu, W. (2011) · The Annals of Statistics · doi:10.1214/10-aos844 · Cited by 35
Sequential Methods for Parametric Survival Models
Tsiatis, A. A., BOUCHER, H., & Kim, K. S. (1995) · Biometrika · doi:10.1093/biomet/82.1.165 · Cited by 35
Black, H. R., Elliott, W. J., Granditis, G. A., & Grambsch, P. M. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00275-7 · Cited by 35
Sequential methods and group sequential designs for comparative clinical trials
Sebille, V., & Bellissant, É. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00192.x · Cited by 35
Monitoring Clinical Trials with Multiple Arms
Hellmich, M. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00892.x · Cited by 35
Biostatistical Collaboration in Medical Research
Ellenberg, J. H., Armitage, P., Chalmers, T. C., Gehan, E. A., O'Fallon, J. R., Pocock, S., & Zelen, M. (1990) · Biometrics · doi:10.2307/2531627 · Cited by 35
MacArthur, R. D., Chen, L., Mayers, D. L., Besch, C. L., Novak, R. M., van den Berg-Wolf, M., Yurik, T. M., Peng, G., Schmetter, B., Brizz, B., et al. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00111-8 · Cited by 35
The state of cumulative sum sequential changepoint testing 70 years after Page
Aue, A., & Kirch, C. (2023) · Biometrika · doi:10.1093/biomet/asad079 · Cited by 34
Flexible Implementations of Group Sequential Stopping Rules Using Constrained Boundaries
Burington, B. E., & Emerson, S. S. (2003) · Biometrics · doi:10.1111/j.0006-341x.2003.00090.x · Cited by 34
Sequential Methods for Comparing Years of Life Saved in the Two‐Sample Censored Data Problem
Murray, S., & Tsiatis, A. A. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01085.x · Cited by 34
Repeated significance testing in longitudinal clinical trials
Lee, S. J. (1996) · Biometrika · doi:10.1093/biomet/83.4.779 · Cited by 34
Hsu, D. T., Mital, S. R., Ravishankar, C., Margossian, R. E., Li, J. S., Sleeper, L. A., Williams, R. V., Levine, J. C., McCrindle, B. W., Atz, A. M., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.08.030 · Cited by 34
Issues in the use of adaptive clinical trial designs
Emerson, S. S. (2006) · Statistics in Medicine · doi:10.1002/sim.2626 · Cited by 34
Power estimations for non-primary outcomes in randomised clinical trials
Jakobsen, J. C., Ovesen, C., Winkel, P., Hilden, J., Gluud, C. N., & Wetterslev, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027092 · Cited by 35
THE EFFECT OF ANTENATAL PHENOBARBITAL THERAPY ON NEONATAL INTRACRANIAL HEMORRHAGE IN PRETERM INFANTS
Hankaran, S. E. S., Apile, P., Right, L. I. L. W., Hrenkranz, R. I. A. E., Ele, L. I. M., Emons, J., Orones, S. H. B. K., Tevenson, D. A. K. S., Dward, E., Onovan, F. D., et al. (1997) · Cited by 34
Prophylactic Coronary Artery Revascularization for Elective Vascular Surgery
McFalls, E. O., Ward, H. B., Krupski, W. C., Goldman, S., Littooy, F. N., Eagle, K. A., Nyman, J. A., MORITZ, T. E., McNabb, S., & Henderson, W. G. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00004-5 · Cited by 34
Sequential Testing in Clinical Trials with Repeated Measurements
Geary, D. N. (1988) · Biometrika · doi:10.1093/biomet/75.2.311 · Cited by 34
Hungria, V., Robak, P., Hus, M., Zherebtsova, V., Ward, C., Ho, P. J., Hájek, R., Kim, K., Grosicki, S., Sia, H., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00330-4 · Cited by 35
On Adaptive Extensions of Group Sequential Trials for Clinical Investigations
Liu, Q., & Anderson, K. M. (2008) · Journal of the American Statistical Association · doi:10.1198/016214508000000986 · Cited by 33
Jaki, T., & Magirr, D. (2012) · Statistics in Medicine · doi:10.1002/sim.5669 · Cited by 33
Information-based monitoring of clinical trials
Tsiatis, A. A. (2006) · Statistics in Medicine · doi:10.1002/sim.2625 · Cited by 33
Elshazli, R. M., Toraih, E. A., Elgaml, A., Kandil, E. H., & Fawzy, M. S. (2020) · Gene · doi:10.1016/j.gene.2020.144391 · Cited by 33
Continuous Positive Airway Pressure for Treatment of Postoperative Hypoxemia
Squadrone, V., Coha, M., Cerutti, E., Schellino, M. M., Biolino, P., Occella, P., Belloni, G., Vilianis, G., Fiore, G., Cavallo, F., et al. (2013) · Cited by 33
A New Class of Completely Self‐Designing Clinical Trials
Hartung, J. G., & Knapp, G. (2003) · Biometrical Journal · doi:10.1002/bimj.200290014 · Cited by 33
Stallard, N., & Facey, K. M. (1996) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409608835149 · Cited by 33
Group Sequential Designs: A TutorialPreprint
Lakens, D., Pahlke, F., & Wassmer, G. (2021) · doi:10.31234/osf.io/x4azm · Cited by 36
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer
Ventz, S., Alexander, B. M., Parmigiani, G., Gelber, R. D., & Trippa, L. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1169 · Cited by 33
Sheldon, R., Talajic, M., Tang, A., Becker, G., Essebag, V., Sultan, O., Baranchuk, A., Ritchie, D., Morillo, C., Krahn, A., et al. (2022) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2021.10.003 · Cited by 32
Murray, K. F., Rodrigue, J. R., González‐Peralta, R. P., Shepherd, J., BARTON, B. A., Robuck, P. R., & Schwarz, K. B. (2007) · Clinical Trials · doi:10.1177/1740774507085445 · Cited by 32
Review of Draft FDA Adaptive Design Guidance
Cook, T. D., & DeMets, D. L. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2010.514455 · Cited by 32
Self-citationGilbert, P. B., Grove, D. I., Gabriel, E. E., Huang, Y., Gray, G., Hammer, S. M., Buchbinder, S., Kublin, J. G., Corey, L., & Self, S. G. (2011) · Statistical Communications in Infectious Diseases · doi:10.2202/1948-4690.1037 · Cited by 32
Emerson, S. S., Levin, G. P., & Emerson, S. C. (2011) · Statistics in Medicine · doi:10.1002/sim.4271 · Cited by 32
A Bayesian group sequential design for a multiple arm randomized clinical trial
Rosner, G. L., & Berry, D. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140405 · Cited by 32
Design and Analysis of Group Sequential Logrank Tests in Maximum Duration Versus Information Trials
Kim, K., BOUCHER, H., & Tsiatis, A. A. (1995) · Biometrics · doi:10.2307/2532999 · Cited by 32
Carlin, B. P., Chaloner, K. M., Church, T. R., Louis, T. A., & Matts, J. P. (1993) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348470 · Cited by 32
Commentary: Which meta-analyses are conclusive?
Nüesch, E., & Jüni, P. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn265 · Cited by 32
The Effect of Intensive Care Unit Diaries on Posttraumatic Stress Disorder, Anxiety, and Depression
Gazzato, A., Scquizzato, T., Imbrìaco, G., Negro, A., Garrido, M. C. C., Landoni, G., Zangrillo, A., & Borghi, G. (2022) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000539 · Cited by 37
Bayesian adaptive model selection for optimizing group sequential clinical trials
Wathen, J. K., & Thall, P. F. (2008) · Statistics in Medicine · doi:10.1002/sim.3381 · Cited by 31
Kim, J. H., Yoo, C., Seo, S., Jeong, J. H., Ryoo, B., Kim, K., Lee, J. B., Lee, K., Kim, J., Kim, I. H., et al. (2022) · Cancers · doi:10.3390/cancers14030559 · Cited by 31
Mullany, L. C., Arifeen, S. E., WINCH, P. J., Shah, R., Mannan, I., Rahman, S. M., Rahman, M. R., Darmstadt, G. L., Ahmed, S., Santosham, M., et al. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-67 · Cited by 31
Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer
Murray, T. A., Thall, P. F., Yuan, Y., McAvoy, S., & Gomez, D. R. (2016) · Journal of the American Statistical Association · doi:10.1080/01621459.2016.1176926 · Cited by 31
Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS)
Afshari, A., Bille, A. B., & Allingstrup, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007733.pub3 · Cited by 31
Presentation of Nonfinal Results of Randomized Controlled Trials at Major Oncology Meetings
Booth, C. M., Maître, A. L., Ding, K., Farn, K., Fralick, M., Phillips, C., Cescon, D. W., & Meyer, R. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8771 · Cited by 31
Hirota, W. K., Wortmann, G. W., Maydonovitch, C. L., Chang, A. S., Midkiff, R. B., Wong, R. K. H., & Moses, F. M. (1999) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(99)70068-4 · Cited by 31
Buonanno, P., Marra, A., Iacovazzo, C., Vargas, M., Coviello, A., Squillacioti, F., Nappi, S., de Siena, A. U., & Servillo, G. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.09.011 · Cited by 32
Toft, P., Olsen, H. T., Jørgensen, H. K., Strøm, T., Nibro, H. L., Oxlund, J., Wian, K., Ytrebø, L. M., Kroken, B. A., & Chew, M. S. (2014) · Trials · doi:10.1186/1745-6215-15-499 · Cited by 30
Pritchett, Y., Jemiai, Y., Chang, Y., Bhan, I., Agarwal, R., Zoccali, C., Wanner, C., Lloyd‐Jones, D. M., Cannata-Andía, J. B., Thompson, B., et al. (2011) · Clinical Trials · doi:10.1177/1740774511399128 · Cited by 30
Currier, J. S., Britto, P., Hoffman, R. M., Brummel, S. S., Masheto, G. R., Joao, E. C., Santos, B. R., Aurpibul, L., Losso, M. H., Pierre, M. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176009 · Cited by 30
Mazzone, P. J., Obuchowski, N. A., Phillips, M. D., Risius, B., Bazerbashi, B., & Meziane, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059650 · Cited by 30
Extended-Release Physostigmine in Alzheimer Disease
van Dyck, C. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.157 · Cited by 29
Bayesian Monitoring of Clinical Trials with Failure‐Time Endpoints
Rosner, G. L. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.031037.x · Cited by 30
Group sequential testing in clinical trials with multivariate observations: A review
Lee, J. W. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130202 · Cited by 30
Group sequential extensions of a standard bioequivalence testing procedure
Gould, A. L. (1995) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353786 · Cited by 30
Ellenberg, S. S., Myers, M. W., Blackwelder, W. C., & Hoth, D. F. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120510 · Cited by 30
Serruys, P. W. J. C., de Feyter, P. J., Benghozi, R., Hugenholtz, P. G., & Lesaffre, E. M. E. H. (2001) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840127765 · Cited by 30
Basic concepts of group sequential and adaptive group sequential test procedures
Wassmer, G. (2000) · Statistical Papers · doi:10.1007/bf02925923 · Cited by 30
Metadata
- Authors
- GORDON LAN, K. K., & DEMETS, D. L.
- Affiliations
- University of Wisconsin–Madison (US)
- Venue
- Biometrika
- Publisher
- Oxford University Press (OUP)
- Published
- 1983
- Volume
- 70
- Issue
- 3
- Pages
- 659-663
- ISSN
- 0006-3444 (ISSN-L)
- 1464-3510
- OpenAlex
- W1990639292
- Cited by
- 2,310
- References
- 10
- Citations by year
- 2026: 51 · 2025: 69 · 2024: 80 · 2023: 78 · 2022: 63 · 2021: 73 · 2020: 77 · 2019: 96 · 2018: 76 · 2017: 89 · 2016: 90 · 2015: 72 · 2014: 112 · 2013: 73 · 2012: 101
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biometrika (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Keywords
- clinical trials, early stopping, alpha spending functions, sequential analysis, decision time, error rate control
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review